SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CELLDEX THERAPEUTICS SHARES FALL 3% AFTER THE BELL FOLLOWING PHASE 2 STUDY RESULTS

CLDX

Related stories